These Healthcare stocks are trading higher:
-Geron Corporation (GERN) stock is trading at $1.67, an increase of $0.26, or 23.52%, on high volume. Geron Corp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.50.
-AnPac Bio-Medical Science Co Ltd - ADR (ANPC) stock is trading at $5.20, an increase of $0.87, or 19.86%, on high volume. Anpac Bio-Medical Science CO ADR gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Sell with a price target of $8.00.
-CureVac BV (CVAC) stock is trading at $65.92, an increase of $8.09, or 14.25%, on high volume. Curevac N.V. gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $84.00.
-Gbs Inc (GBS) stock is trading at $4.62, a gain of $0.3, or 6.94%, on low volume. Gbs Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Sell.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-CytRx Corporation (CYTR) stock is trading at $1.25, a drop of $1.57, or 54.97%, on high volume. Cytrx Corp gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Sell.
-Athira Pharma Inc (ATHA) stock is trading at $10.71, a loss of $7.53, or 41.69%, on high volume. Athira Pharma Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $42.33.
-Orphazyme A S ADR (ORPH) stock is trading at $9.07, a loss of $5.49, or 40.81%, on high volume. Orphazyme A/S ADR gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $16.00.
-Chinook Therapeutics Inc (KDNY) stock is trading at $13.56, a decline of $2.44, or 14.28%, on high volume. Chinook Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $32.71.
